Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Seven Billion Microcosms: Evolution within Human Microbiomes.

Lieberman TD.

mSystems. 2018 Mar 20;3(2). pii: e00171-17. doi: 10.1128/mSystems.00171-17. eCollection 2018 Mar-Apr.

2.

Global and local selection acting on the pathogen Stenotrophomonas maltophilia in the human lung.

Chung H, Lieberman TD, Vargas SO, Flett KB, McAdam AJ, Priebe GP, Kishony R.

Nat Commun. 2017 Jan 19;8:14078. doi: 10.1038/ncomms14078.

3.

Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis.

Lieberman TD, Wilson D, Misra R, Xiong LL, Moodley P, Cohen T, Kishony R.

Nat Med. 2016 Dec;22(12):1470-1474. doi: 10.1038/nm.4205. Epub 2016 Oct 31.

4.

Compounds that select against the tetracycline-resistance efflux pump.

Stone LK, Baym M, Lieberman TD, Chait R, Clardy J, Kishony R.

Nat Chem Biol. 2016 Nov;12(11):902-904. doi: 10.1038/nchembio.2176. Epub 2016 Sep 19.

5.

Spatiotemporal microbial evolution on antibiotic landscapes.

Baym M, Lieberman TD, Kelsic ED, Chait R, Gross R, Yelin I, Kishony R.

Science. 2016 Sep 9;353(6304):1147-51. doi: 10.1126/science.aag0822.

6.

A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway.

Wang KK, Stone LK, Lieberman TD, Shavit M, Baasov T, Kishony R.

Mol Biol Evol. 2016 Feb;33(2):492-500. doi: 10.1093/molbev/msv243. Epub 2015 Nov 3.

7.

Inexpensive multiplexed library preparation for megabase-sized genomes.

Baym M, Kryazhimskiy S, Lieberman TD, Chung H, Desai MM, Kishony R.

PLoS One. 2015 May 22;10(5):e0128036. doi: 10.1371/journal.pone.0128036. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0131262.

8.

Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance.

Kim S, Lieberman TD, Kishony R.

Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14494-9. doi: 10.1073/pnas.1409800111. Epub 2014 Sep 22.

9.

Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures.

Lieberman TD, Flett KB, Yelin I, Martin TR, McAdam AJ, Priebe GP, Kishony R.

Nat Genet. 2014 Jan;46(1):82-7. doi: 10.1038/ng.2848. Epub 2013 Dec 8.

10.

An objective function exploiting suboptimal solutions in metabolic networks.

Wintermute EH, Lieberman TD, Silver PA.

BMC Syst Biol. 2013 Oct 3;7:98. doi: 10.1186/1752-0509-7-98.

11.

Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection.

Skurnik D, Davis MR Jr, Benedetti D, Moravec KL, Cywes-Bentley C, Roux D, Traficante DC, Walsh RL, Maira-LitrĂ n T, Cassidy SK, Hermos CR, Martin TR, Thakkallapalli EL, Vargas SO, McAdam AJ, Lieberman TD, Kishony R, Lipuma JJ, Pier GB, Goldberg JB, Priebe GP.

J Infect Dis. 2012 Jun;205(11):1709-18. doi: 10.1093/infdis/jis254. Epub 2012 Mar 23.

12.

Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes.

Lieberman TD, Michel JB, Aingaran M, Potter-Bynoe G, Roux D, Davis MR Jr, Skurnik D, Leiby N, LiPuma JJ, Goldberg JB, McAdam AJ, Priebe GP, Kishony R.

Nat Genet. 2011 Nov 13;43(12):1275-80. doi: 10.1038/ng.997.

13.

Towards a synthetic chloroplast.

Agapakis CM, Niederholtmeyer H, Noche RR, Lieberman TD, Megason SG, Way JC, Silver PA.

PLoS One. 2011 Apr 20;6(4):e18877. doi: 10.1371/journal.pone.0018877.

Supplemental Content

Loading ...
Support Center